Administration of Secretome Derived from Human Mesenchymal Stem Cells Induces Hepatoprotective Effects in Models of Idiosyncratic Drug-Induced Liver Injury Caused by Amiodarone or Tamoxifen

Vista sencilla de ítem
dc.contributor.authorHuang, Ya-Lin
dc.contributor.authorDe Gregorio, Cristian
dc.contributor.authorSilva, Verónica
dc.contributor.authorElorza, Álvaro A.
dc.contributor.authorLéniz, Patricio
dc.contributor.authorAliaga-Tobar, Víctor
dc.contributor.authorMaracaja-Coutinho, Vinicius
dc.contributor.authorBudini, Mauricio
dc.contributor.authorEzquer, Fernando
dc.contributor.authorMarcelo, Ezquer
dc.date.accessioned2023-07-20T15:00:18Z
dc.date.available2023-07-20T15:00:18Z
dc.date.issued2023-02
dc.descriptionIndexación Scopuses
dc.description.abstractDrug-induced liver injury (DILI) is one of the leading causes of acute liver injury. While many factors may contribute to the susceptibility to DILI, obese patients with hepatic steatosis are particularly prone to suffer DILI. The secretome derived from mesenchymal stem cell has been shown to have hepatoprotective effects in diverse in vitro and in vivo models. In this study, we evaluate whether MSC secretome could improve DILI mediated by amiodarone (AMI) or tamoxifen (TMX). Hepatic HepG2 and HepaRG cells were incubated with AMI or TMX, alone or with the secretome of MSCs obtained from human adipose tissue. These studies demonstrate that coincubation of AMI or TMX with MSC secretome increases cell viability, prevents the activation of apoptosis pathways, and stimulates the expression of priming phase genes, leading to higher proliferation rates. As proof of concept, in a C57BL/6 mouse model of hepatic steatosis and chronic exposure to AMI, the MSC secretome was administered endovenously. In this study, liver injury was significantly attenuated, with a decrease in cell infiltration and stimulation of the regenerative response. The present results indicate that MSC secretome administration has the potential to be an adjunctive cell-free therapy to prevent liver failure derived from DILI caused by TMX or AMI.es
dc.identifier.citationCells Volume 12, Issue 4February 2023 Article number 636es
dc.identifier.doi10.3390/cells12040636en
dc.identifier.issn2073-4409
dc.identifier.urihttps://repositorio.unab.cl/xmlui/handle/ria/51840
dc.language.isoenes
dc.publisherCellses
dc.rights.licenseAttribution 4.0 International (CC BY 4.0)en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en
dc.subjectamiodaronees
dc.subjectcell free therapyes
dc.subjectdrug-induced liver injuryes
dc.subjecthepatic regenerationes
dc.subjecttamoxifenes
dc.titleAdministration of Secretome Derived from Human Mesenchymal Stem Cells Induces Hepatoprotective Effects in Models of Idiosyncratic Drug-Induced Liver Injury Caused by Amiodarone or Tamoxifenes
dc.typeArtículoes
Archivos
Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
Administration-of-Secretome-Derived-from-Human-Mesenchymal-Stem-Cells-Induces-Hepatoprotective-Effects-in-Models-of-Idiosyncratic-DrugInduced-Liver-Injury-Caused-by-Amiodarone-or-TamoxifenCells.pdf
Tamaño:
14.96 MB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLÉS
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Colecciones
Fac.CV - Artículos de Revista